Home
    Disclaimer
    This substance involves MAOI activity. Dangerous interactions can occur with many common foods and medications. Research contraindications thoroughly.

    Tranylcypromine Encyclopedic
    Encyclopedic
    Typical encyclopedia coverage. Cross-reference for important decisions.
    • 2 corroborating sources
    • 1 ROA with full dose ladder
    • duration data present
    • 18 combo interactions documented
    • PubChem toxicity data
    • dose data not in PW/TripSit (unverifiable)

    Aliases: Tcp, 2-pcpa, Parnate, Skf-385

    Summary TheDrug.Wiki

    Tranylcypromine is a non-selective, irreversible MAOI typically reserved for treatment-resistant major depressive disorder. Requires strict dietary restrictions to avoid tyramine-rich foods, which can cause life-threatening hypertensive crisis. Allow adequate washout periods when switching from other antidepressants (typically 2 weeks, but 5 weeks for fluoxetine).

    Dose Information TheDrug.Wiki

    No curated dose ladder is available for this substance. The figures below are drawn from SubstanceIndex (DoseWiki) as a fallback — often a conservative threshold only. Treat them as approximate and cross-reference before use.

    ROA Light Common Strong Heavy
    Oral 10-20mg 30-40mg 50-60mg 60mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki

    Effect Profile

    2 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Stimulant 4.9
    Moderate+ 5/10

    Moderate stimulation, euphoria, and anxiety/jitters

    Stimulation / Energy ×3
    7
    stimulation increased energy alertness enhancement
    Euphoria / Mood Lift ×2
    7
    cognitive euphoria mood lift mood elevation
    Focus / Productivity ×2
    0
    Anxiety / Jitters ×1
    6
    anxiety restlessness

    Tolerance

    Build-up develops over days to weeks of regular use
    Reset 3–7 days for acute; 1–3 weeks for full reset

    Tolerance Decay

    Half tolerance 3d Baseline ~21d

    Classical recreational-style tolerance modeling is not applicable. Clinical “tolerance” to antidepressant effect may not develop; however, receptor adaptations and withdrawal phenomena can occur with abrupt cessation. Cross‑tolerance applies pharmacodynamically to other irreversible MAOIs (phenelzine, isocarboxazid).

    Effects TheDrug.Wiki

    Positive
    • Stimulation
    • Increased energy
    • Anxiolysis
    Negative
    • Insomnia
    • Restlessness
    • Headache
    • Dry mouth
    • Insomnia or sleep disturbances
    Neutral
    • Orthostatic hypotension
    • Sedation
    Positive
    • Mood lift
    • Alertness enhancement
    • Mood elevation
    • Improved motivation
    • Enhanced sociability
    • Cognitive Euphoria
    Negative
    • Anxiety
    • Agitation
    • Dizziness
    Neutral
    • Talkativeness
    Positive
    • Increased music appreciation
    • Perception of bodily lightness
    • Tactile enhancement
    Negative
    • Light sensitivity
    • Decreased Libido
    • Appetite Suppression
    • Disinhibition
    Neutral
    • Dulled perception
    • Sexual Dysfunction
    • Spontaneous physical sensations

    Combinations TripSit

    Cross-Check Tranylcypromine with another substance

    Community Trip Reports

    Anecdotal first-person accounts from Reddit, Erowid, and Bluelight. Click a source to expand. Reports are harm-reduction context, not medical guidance.

    Erowid 1 report 1 neutral visit
    Psychiatric Use neutral exp #106885

    After trying 11 other antidepressants and countless other classes of psychiatric drugs (been on psych meds the past 14 years), an enlightened doctor finally prescribed me a MAOI. I take trancylpromine (Parnate), currently 20 mg in the morning (around 6 am) and 10 mg around noon.

    mouse · 30 - 50 mg oral / 900 mg oral / 50 ug oral / 0.5 mg oral

    Pill Identifiers

    Helpful Links